CIGB2020- ARI elderly contacts

Not Applicable

• Conditions: Acute Respiratory Infection (ARI); COVID-19; SARS-CoV2; Respiratory Tract Diseases; Respiratory Tract Infections; Coronavirus Infections; SARS Virus; Coronaviridae Infections; Nidovirales Infections; Betacoronavirus

• Registration Number: RPCEC00000356
• Lead Sponsor: Center for Genetic Engineering and Biotechnology (CIGB)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-11
• Study Completion: 2021-08-31
• Results First Posted: 2021-09-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 1440

Inclusion Criteria

1. Adults = 60 years old, both sexes.
2. All subjects = 60 years old, contacts of patients diagnosed with flu, cold, dengue fever, SARS-CoV2 or other acute respiratory infections to be randomized during the study.
3. Subjects having agreed their informed consent to participate in the study.

Exclusion Criteria

1. Diagnostic of SARS-CoV-2 infection since the day 14th previous to recruitment.
2. Use of immunosuppressor drugs during one month previous to recruitment.
3. Liver cirrhosis by HBV or liver transplant due to HBV.
4. Any problem avoiding the addequate follow-up of the contact older than sixty.
5. Terminal disease at the moment of recruitment.
6. History of allergy to some of the ingredients of the vaccine under study
7. Pregnancy or lactancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified